ArticleInternational journal of general medicine2026
Clinical Characteristics and Risk Factors for Major Adverse Cardiovascular Events in Patients on Maintenance Hemodialysis: A Retrospective Study.
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Patients on maintenance hemodialysis face a disproportionately high burden of cardiovascular disease, with major adverse cardiovascular events being the leading cause of death. However, the relative importance and specific roles of traditional versus non-traditional risk factors in this unique population require further elucidation in clinical practice. This study aimed to investigate the risk factors for major adverse cardiovascular events in patients undergoing maintenance hemodialysis, thereby providing evidence for clinical risk stratification and early intervention. Methods: A single-center retrospective study was carried out, enrolling 196 patients with end-stage renal disease who received regular MHD (duration ≥ 6 months) between January 2021 and August 2022. According to MACE occurrence during follow-up, patients were categorized into MACE (n = 66) and non-MACE (n = 130) groups. Baseline characteristics, comorbidities, and laboratory parameters were collected. Logistic regression analysis was utilized to assess independent risk factors for MACEs, and their predictive value was evaluated using receiver operating characteristic (ROC) curve analysis. Results: Over a 21-month follow-up, the cumulative MACE incidence was 33.67%. Multivariate analysis revealed that serum albumin was an independent protective factor for MACEs (OR = 0.679, 95% CI: 0.558-0.827, P < 0.01), whereas C-reactive protein (CRP) was an independent risk factor (OR = 1.151, 95% CI: 0.994-1.334, P = 0.046). ROC curve analysis demonstrated that the combination of serum albumin and CRP provided the best predictive performance, with an area under the curve (AUC) of 0.7224 (sensitivity 81.77%, specificity 51.52%). Conclusion: Low serum albumin and elevated CRP are independent risk factors for MACEs in MHD patients. The combined assessment of these two biomarkers offers good predictive value for MACEs and may serve as an effective tool for clinical screening of high-risk patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.